Bernd Jilma Selected Research

Bernd Jilma Research Topics

Disease

43	Inflammation (Inflammations) 04/2022 - 02/2002
37	Endotoxemia 01/2022 - 05/2002
30	Hemorrhage 01/2022 - 12/2003
21	Thrombosis (Thrombus) 04/2022 - 11/2002
19	Myocardial Infarction 06/2022 - 09/2004
19	Sepsis (Septicemia) 01/2020 - 10/2002
17	Acute Coronary Syndrome 01/2022 - 10/2002
13	Stroke (Strokes) 01/2021 - 04/2003
12	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 10/2003
11	COVID-19 01/2022 - 10/2020
10	Disseminated Intravascular Coagulation 01/2022 - 05/2002
10	Infections 07/2016 - 02/2006
9	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2022 - 01/2019
9	Atherosclerosis 12/2020 - 09/2004
8	ST Elevation Myocardial Infarction 04/2022 - 06/2010
8	Heart Arrest (Cardiac Arrest) 02/2022 - 03/2009
8	Critical Illness (Critically Ill) 01/2020 - 10/2002
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 01/2006
7	Neoplasms (Cancer) 01/2020 - 02/2006
7	Chronic Hepatitis C 01/2020 - 02/2006
7	Thrombocytopenia (Thrombopenia) 07/2016 - 10/2002
6	Ischemic Stroke 06/2022 - 09/2004
6	Mastocytosis 01/2022 - 01/2019
6	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2019
6	Hemolysis 01/2022 - 02/2003
6	Out-of-Hospital Cardiac Arrest 09/2021 - 10/2018
6	Thrombotic Thrombocytopenic Purpura 04/2015 - 10/2009
5	Unstable Angina 01/2022 - 03/2005
5	Birth Weight (Birth Weights) 01/2020 - 07/2006
4	Body Weight (Weight, Body) 01/2022 - 01/2009
4	Heart Failure 11/2021 - 11/2019
4	Septic Shock (Toxic Shock Syndrome) 10/2020 - 12/2015
4	Bacteremia 01/2020 - 10/2002
3	Hypothermia 02/2022 - 07/2009
3	Type 2 von Willebrand Disease 01/2022 - 09/2010
3	Diabetes Mellitus 01/2021 - 07/2013
3	Venous Thromboembolism 01/2020 - 08/2006
3	Necrosis 07/2018 - 02/2007

Drug/Important Bio-Agent (IBA)

24	von Willebrand FactorIBA 01/2022 - 04/2004
15	TicagrelorIBA 01/2022 - 11/2010
14	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 04/2003
13	CytokinesIBA 01/2022 - 11/2002
13	C-Reactive ProteinIBA 09/2021 - 10/2006
13	Clopidogrel (Plavix)FDA Link 11/2020 - 04/2003
13	Thromboplastin (Tissue Factor)IBA 01/2020 - 05/2002
13	EndotoxinsIBA 05/2018 - 02/2002
12	Interleukin-6 (Interleukin 6)IBA 11/2021 - 01/2004
11	Pharmaceutical PreparationsIBA 02/2022 - 09/2003
11	Thrombin FDA Link 01/2020 - 09/2003
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2004
10	AnticoagulantsIBA 01/2022 - 05/2002
10	fibrin fragment D (D-dimer)IBA 12/2021 - 05/2002
10	VaccinesIBA 08/2021 - 11/2008
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2002
8	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2011
8	ARC 1779IBA 08/2012 - 08/2009
7	Histamine (Histamine Dihydrochloride)FDA Link 04/2022 - 12/2015
7	sutimlimabIBA 01/2022 - 01/2019
7	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 01/2003
7	Adenosine Diphosphate (ADP)IBA 01/2018 - 09/2004
6	Hemoglobins (Hemoglobin)IBA 01/2022 - 10/2006
6	EnzymesIBA 01/2022 - 11/2008
6	Prasugrel Hydrochloride FDA Link 01/2021 - 11/2012
6	FibrinIBA 01/2021 - 05/2002
6	AntigensIBA 01/2020 - 02/2006
6	CollagenIBA 01/2020 - 09/2004
6	thiamine triphosphorate (TTP)IBA 02/2016 - 10/2009
5	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 02/2014
5	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 10/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 02/2002
5	AntibodiesIBA 11/2021 - 06/2006
5	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 07/2020 - 03/2005
5	Fibrinogen (Factor I)FDA Link 02/2018 - 01/2007
5	Messenger RNA (mRNA)IBA 03/2017 - 09/2003
5	Glycoproteins (Glycoprotein)IBA 11/2016 - 02/2003
5	LipopolysaccharidesIBA 03/2009 - 02/2002
4	Amine Oxidase (Copper-Containing)IBA 04/2022 - 01/2018
4	BilirubinIBA 01/2021 - 02/2018
4	TabletsIBA 01/2021 - 01/2015
4	Complement System Proteins (Complement)IBA 01/2021 - 01/2019
4	Platelet Membrane Glycoprotein IIbIBA 11/2016 - 12/2003
3	Platelet Membrane GlycoproteinsIBA 01/2022 - 01/2020
3	Complement C1s (C1 Esterase)IBA 01/2022 - 01/2019
3	Erythropoietin FDA Link 01/2021 - 07/2006
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021 - 01/2020
3	Prothrombin (Factor II)IBA 10/2020 - 10/2006
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020 - 02/2010
3	Protein CIBA 06/2019 - 09/2003
3	P-SelectinIBA 07/2018 - 02/2003
3	vasodilator-stimulated phosphoproteinIBA 01/2018 - 11/2008
3	Purinergic P2Y Receptor AntagonistsIBA 11/2016 - 07/2013

Therapy/Procedure

26	Therapeutics 01/2021 - 10/2002
9	Percutaneous Coronary Intervention 12/2020 - 03/2005
6	Stents 04/2022 - 07/2013
5	Induced Hypothermia 02/2022 - 07/2009
4	Heart-Assist Devices 11/2019 - 01/2009
3	Critical Care (Surgical Intensive Care) 02/2022 - 05/2016
3	Length of Stay 10/2021 - 12/2012
3	Subcutaneous Injections 08/2021 - 01/2020
3	Electrodes (Electrode) 01/2017 - 09/2013